Lv1
30 积分 2021-08-19 加入
Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma
21小时前
已完结
Soluble B‐cell maturation antigen in multiple myeloma
2天前
已完结
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
10天前
已完结
Secretion of 4-1BB Ligand Crosslinked to PD-1 Checkpoint Inhibitor Potentiates Chimeric Antigen Receptor T Cell Solid Tumor Efficacy
11天前
已完结
Phospho-proteomics reveals that RSK signaling is required for proliferation of natural killer cells stimulated with IL-2 or IL-15
11天前
已完结
Handling the different requirements for commercial and investigational MNC collections by apheresis
13天前
已完结
Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Multiple Myeloma
15天前
已完结
Honing CAR T cells to tackle acute myeloid leukemia
15天前
已关闭
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
22天前
已完结
Novel strategies to manage CAR-T cell toxicity
26天前
已完结
皖公网安备34019202002308
